Alexandra Sergeevna Shadrina

Alexandra Sergeevna Shadrina

Auto-generated profile, based on publicly available information

Alexandra Sergeevna Shadrina

Laboratory of Theoretical and Applied Functional Genomics, Novosibirsk State University, Novosibirsk, Russia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ASAlexandra S. Shadrina
Alexandra S. Shadrina
SSSodbo Sharapov
Sodbo Sharapov
TSTatiana I. Shashkova
Tatiana I. Shashkova
YTYakov Tsepilov
Yakov Tsepilov
Varicose veins of lower extremities (VVs) are a common multifactorial vascular disease. Genetic factors underlying VVs development remain largely unknown. Here we report the first large-scale study of VVs performed on a freely available genetic data of 408,455 European-ancestry individuals. We identified the 12 reliably associated loci that explain 13% of the SNP-based heritability, and prioritized the most likely causal genes CASZ1, PIEZO1, PPP3R1, EBF1, STIM2, HFE, GATA2, NFATC2, and SOX9. VVs-associated variants within these loci exhibited pleiotropic effects on several phenotypes including blood pressure/hypertension and blood cell traits. Gene set enrichment analysis revealed gene categories related to abnormal vasculogenesis. Genetic correlation analysis confirmed known epidemiological associations between VVs and deep venous thrombosis, weight, rough labor, and standing job, and found a genetic overlap with multiple traits that have not been previously suspected to share common genetic background with VVs. These traits included educational attainment, fluid intelligence and prospective memory scores, walking pace (negative correlation with VVs), smoking, height, number of operations, pain, and gonarthrosis (positive correlation with VVs). Finally, Mendelian randomization analysis provided evidence for causal effects of plasma levels of MICB and CD209 proteins, and anthropometric traits such as waist and hip circumference, height, weight, and both fat and fat-free mass. Our results provide novel insight into both VVs genetics and etiology. The revealed genes and proteins can be considered as good candidates for follow-up functional studies and might be of interest as potential drug targets. Varicose veins of lower extremities (VVs) affect about 30% of adults in developed countries and cause both cosmetic and health problems. A strong body of evidence indicates that heredity plays an important role in the etiology of this condition. However, genetic basis of VVs remains poorly understood. Here, we present the results of the first large-scale genetic study for VVs. We identified genes which are the most likely involved in VVs pathogenesis. We show that VVs are correlated at a genetic level with numerous traits and phenotypes, including those already known from prior epidemiological studies (deep venous thrombosis, body mass index, standing job, etc.) as well as with those that have not been suspected to share common genetic background with VVs (fluid intelligence and prospective memory scores, smoking, walking pace, leg pain and pain all over the body, and other traits). Finally, using genetic variants as instruments, we demonstrate direct causal effects of the traits related to anthropometry, such as height and weight, and plasma levels of immune-related proteins MICB and CD209. Our study provides novel insight into both VVs genetics and etiology. The revealed genes (CASZ1, PIEZO1, PPP3R1, EBF1, STIM2, HFE, GATA2, NFATC2, and SOX9) and proteins (MICB and CD209) can be considered as good candidates for follow-up functional studies and might be of interest as potential drug targets.

25 June 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
YTYakov Tsepilov
Yakov Tsepilov
MFMaxim B. Freidin
Maxim B. Freidin
ASAlexandra S. Shadrina
Alexandra S. Shadrina
SSSodbo Sharapov
Sodbo Sharapov
EEElizaveta Evgenevna Elgaeva
Elizaveta Evgenevna Elgaeva
YAYurii S. Aulchenko
Yurii S. Aulchenko
Chronic musculoskeletal pain affects all aspects of human life. However, mechanisms of its genetic control remain poorly understood. Genetic studies of pain are complicated by the high complexity and heterogeneity of pain phenotypes. Here, we apply principal component analysis to reduce phenotype heterogeneity of chronic musculoskeletal pain at four locations: the back, neck/shoulder, hip, and knee. Using matrices of genetic covariances, we constructed four genetically independent phenotypes (GIPs) with the leading GIP (GIP1) explaining 78.4% of the genetic variance of the analyzed conditions, and GIP2–4 explain progressively less. We identified and replicated five GIP1-associated loci and one GIP2-associated locus and prioritized the most likely causal genes. For GIP1, we showed enrichment with multiple nervous system-related terms and genetic correlations with anthropometric, sociodemographic, psychiatric/personality traits and osteoarthritis. We suggest that GIP1 represents a biopsychological component of chronic musculoskeletal pain, related to physiological and psychological aspects and reflecting pain perception and processing.

30 April 2012 in Cancer Epidemiology
Verified
Journal Article
Closed access
AWAlexandra S. Weiner
Alexandra S. Weiner
UBUljana A. Boyarskikh
Uljana A. Boyarskikh
EVElena N. Voronina
Elena N. Voronina
ISInna A. Selezneva
Inna A. Selezneva
TSTatiana V. Sinkina
Tatiana V. Sinkina
MFMaxim L. Filipenko
Maxim L. Filipenko

1 January 2014 in Gene
Verified
Journal Article
Closed access
AWAlexandra S. Weiner
Alexandra S. Weiner
UBUljana A. Boyarskikh
Uljana A. Boyarskikh
EVElena N. Voronina
Elena N. Voronina
OMOlga V. Mishukova
Olga V. Mishukova
MFMaxim L. Filipenko
Maxim L. Filipenko

11 March 2019 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
SSSodbo Sharapov
Sodbo Sharapov
YTYakov Tsepilov
Yakov Tsepilov
LKLucija Klaric
Lucija Klaric
MMMassimo Mangino
Massimo Mangino
GTGaurav Thareja
Gaurav Thareja
YAYurii S Aulchenko
Yurii S Aulchenko
Glycosylation is a common post-translational modification of proteins. Glycosylation is associated with a number of human diseases. Defining genetic factors altering glycosylation may provide a basis for novel approaches to diagnostic and pharmaceutical applications. Here we report a genome-wide association study of the human blood plasma N-glycome composition in up to 3811 people measured by Ultra Performance Liquid Chromatography (UPLC) technology. Starting with the 36 original traits measured by UPLC, we computed an additional 77 derived traits leading to a total of 113 glycan traits. We studied associations between these traits and genetic polymorphisms located on human autosomes. We discovered and replicated 12 loci. This allowed us to demonstrate an overlap in genetic control between total plasma protein and IgG glycosylation. The majority of revealed loci contained genes that encode enzymes directly involved in glycosylation (FUT3/FUT6, FUT8, B3GAT1, ST6GAL1, B4GALT1, ST3GAL4, MGAT3 and MGAT5) and a known regulator of plasma protein fucosylation (HNF1A). However, we also found loci that could possibly reflect other more complex aspects of glycosylation process. Functional genomic annotation suggested the role of several genes including DERL3, CHCHD10, TMEM121, IGH and IKZF1. The hypotheses we generated may serve as a starting point for further functional studies in this research area.

1 January 2014 in Fertility and Sterility
Verified
Journal Article
Closed access
AWAlexandra S. Weiner
Alexandra S. Weiner
UBUljana A. Boyarskikh
Uljana A. Boyarskikh
EVElena N. Voronina
Elena N. Voronina
ATAlexey E. Tupikin
Alexey E. Tupikin
OKOlga V. Korolkova
Olga V. Korolkova
Maksim Leonidovich FilipenkoMaksim Leonidovich Filipenko
Maksim Leonidovich Filipenko